Cargando…

Mortality estimates and excess mortality in rheumatoid arthritis

OBJECTIVES: To determine long-term (20 year) survival in RA patients enrolled in the Australian Rheumatology Association Database (ARAD). METHODS: ARAD patients with RA and data linkage consent who were diagnosed from 1995 onwards were included. Death data were obtained through linkage to the Austra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Black, Rachel J, Lester, Susan, Tieu, Joanna, Sinnathurai, Premarani, Barrett, Claire, Buchbinder, Rachelle, Lassere, Marissa, March, Lyn, Proudman, Susanna M, Hill, Catherine L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629787/ https://www.ncbi.nlm.nih.gov/pubmed/36919770 http://dx.doi.org/10.1093/rheumatology/kead106

Ejemplares similares

Cardiovascular risk management in rheumatoid and psoriatic arthritis: online survey results from a national cohort study
por: Sinnathurai, Premarani, et al.
Publicado: (2018)

Biologics and cardiovascular events in inflammatory arthritis: a prospective national cohort study
por: Lee, Joshua L., et al.
Publicado: (2018)

Factors associated with oral glucocorticoid use in patients with rheumatoid arthritis: a drug use study from a prospective national biologics registry
por: Black, Rachel J., et al.
Publicado: (2017)

Attitudes of Australians with inflammatory arthritis to biologic therapy and biosimilars
por: Quinlivan, Alannah, et al.
Publicado: (2022)

Patterns of biologic and targeted-synthetic disease-modifying antirheumatic drug use in rheumatoid arthritis in Australia
por: Fletcher, Ashley, et al.
Publicado: (2022)

Vaccination Rates, Perceptions, and Information Sources Used by People With Inflammatory Arthritis
por: Lyon, Andrea, et al.
Publicado: (2023)

Trajectories of self-reported pain-related health outcomes and longitudinal effects on medication use in rheumatoid arthritis: a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
por: Pisaniello, Huai Leng, et al.
Publicado: (2023)

Malignancy risk in Australian rheumatoid arthritis patients treated with anti-tumour necrosis factor therapy: an update from the Australian Rheumatology Association Database (ARAD) prospective cohort study
por: Staples, Margaret P., et al.
Publicado: (2019)

Oral Complementary Medicine Use among People with Inflammatory Arthritis: An Australian Rheumatology Association Database Analysis
por: Fletcher, Ashley, et al.
Publicado: (2020)

Malignancy risk in Australian rheumatoid arthritis patients treated with anti-tumour necrosis factor therapy: analysis of the Australian Rheumatology Association Database (ARAD) prospective cohort study
por: Buchbinder, Rachelle, et al.
Publicado: (2015)

Perspectives of Glucocorticoid Use in Patients with Rheumatoid Arthritis
por: Venter, Gabriella, et al.
Publicado: (2021)

Baseline Comorbidities in a Population-Based Cohort of Rheumatoid Arthritis Patients Receiving Biological Therapy: Data from the Australian Rheumatology Association Database
por: Briggs, Andrew M., et al.
Publicado: (2009)

Ankylosing Spondylitis Patients Commencing Biologic Therapy Have High Baseline Levels of Comorbidity: A Report from the Australian Rheumatology Association Database
por: Oldroyd, John, et al.
Publicado: (2009)

Low copy number of the FCGR3B gene and rheumatoid arthritis: a case-control study and meta-analysis
por: Graf, Scott W, et al.
Publicado: (2012)

Mortality in Korean Patients With Rheumatoid Arthritis
por: Lee, Yeon-Kyung, et al.
Publicado: (2021)

Reduced cardiorespiratory fitness is a mediator of excess all-cause mortality in rheumatoid arthritis: the Trøndelag Health Study
por: Liff, Marthe Halsan, et al.
Publicado: (2021)

Modifiable Lifestyle Factors Associated With Response to Treatment in Early Rheumatoid Arthritis
por: Brown, Zoe, et al.
Publicado: (2020)

Tocilizumab-induced drug reaction with eosinophilia and systemic symptoms (DRESS) in a patient with rheumatoid arthritis
por: Massolino, Rose I, et al.
Publicado: (2018)

Magnetic resonance imaging in psoriatic arthritis: a review of the literature
por: McQueen, Fiona, et al.
Publicado: (2006)

Socioeconomic Status and Medication Use in Rheumatoid Arthritis: A Scoping Review
por: Russell, Oscar, et al.
Publicado: (2022)

Inflammation mediates approximately one quarter of excess relative all-cause mortality in persons with rheumatoid arthritis: the Trøndelag Health Study
por: Videm, Vibeke, et al.
Publicado: (2022)

Using the derived 28-joint disease activity score patient-reported components (DAS28-P) index as a discriminatory measure of response to disease-modifying anti-rheumatic drug therapy in early rheumatoid arthritis
por: Pisaniello, Huai Leng, et al.
Publicado: (2022)

Mortality and Excess Mortality: Improving FluMOMO
por: Portugal, Luís
Publicado: (2021)

Differential expansion of T peripheral helper cells in early rheumatoid arthritis and osteoarthritis synovium
por: Murray-Brown, William, et al.
Publicado: (2022)

Mortality Trends in Rheumatoid Arthritis: Zooming in on Interstitial Lung Disease
por: Reid, Pankti, et al.
Publicado: (2021)

Mortality Trends Among Patients with Rheumatoid Arthritis in Western Australia
por: Almutairi, Khalid B., et al.
Publicado: (2023)

Rheumatoid arthritis and excess mortality: down but not out. A primary care cohort study using data from Clinical Practice Research Datalink
por: Abhishek, Abhishek, et al.
Publicado: (2018)

Attitudes and practices in the laboratory monitoring of conventional synthetic disease modifying anti-rheumatic drugs by rheumatologists and rheumatology trainees
por: Tsakas, James J., et al.
Publicado: (2022)

Artificial intelligence and the future of radiographic scoring in rheumatoid arthritis: a viewpoint
por: Bird, Alix, et al.
Publicado: (2022)

Comparing methods to predict baseline mortality for excess mortality calculations
por: Ferenci, Tamás
Publicado: (2023)

Association between obesity and remission in rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs
por: Abuhelwa, Ahmad Y., et al.
Publicado: (2020)

Statin use and mortality in rheumatoid arthritis: an incident user cohort study
por: Chhibber, Anindit, et al.
Publicado: (2021)

Education and COVID-19 excess mortality
por: Bello, Piera, et al.
Publicado: (2022)

Semiphysiologically Based Pharmacokinetic Model of Leflunomide Disposition in Rheumatoid Arthritis Patients
por: Hopkins, AM, et al.
Publicado: (2015)

Expansions of Cytotoxic CD4(+)CD28(−) T Cells Drive Excess Cardiovascular Mortality in Rheumatoid Arthritis and Other Chronic Inflammatory Conditions and Are Triggered by CMV Infection
por: Broadley, Iain, et al.
Publicado: (2017)

Polymorphisms in cytochrome P450 2C19 enzyme and cessation of leflunomide in patients with rheumatoid arthritis
por: Wiese, Michael D, et al.
Publicado: (2012)

The Association between Systemic Glucocorticoid Use and the Risk of Cataract and Glaucoma in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
por: Black, Rachel J., et al.
Publicado: (2016)

Mortality in Rheumatoid Arthritis (RA): factors associated with recording RA on death certificates
por: Molina, Emily, et al.
Publicado: (2015)

Mortality in patients with rheumatoid arthritis: a 15-year prospective cohort study
por: van den Hoek, J., et al.
Publicado: (2016)

Anti-carbamylated protein autoantibodies associated with mortality in Spanish rheumatoid arthritis patients
por: Vidal-Bralo, Laura, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_gb2lfhgnl7mefnsqfb4haj3h3b